Evidence map›Paper›PMID 32405955›Full record

GuidelineCerebellum (London, England)2020

Management of Patients with Cerebellar Ataxia During the COVID-19 Pandemic: Current Concerns and Future Implications.

Mario Manto, Nicolas Dupre, Marios Hadjivassiliou, Elan D Louis, Hiroshi Mitoma, Marco Molinari, Aasef G Shaikh, Bing-Wen Soong, Michael Strupp, Frank Van Overwalle and 1 more

Open access · hybridAbstract readPractice GuidelineReview
In one paragraph

Guideline in Cerebellum (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Challenges to infection control in early communication intervention: A scoping review.The South African journal of communication disorders = Die Suid-Afrikaanse tydskrif vir Kommunikasieafwykings · 2022
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Impact of SARS-CoV-2 Infection in Spinocerebellar Ataxia 12 Patients.Movement disorders : official journal of the Movement Disorder Society · 2021
    Article
  14. Anxiety and depression in spinocerebellar ataxia patients during the COVID-19 pandemic in China: A cross-sectional study.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2021
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 11 institutions in 8 countries.

Mario MantoUnité des Ataxies Cérébelleuses, Service de Neurologie, CHU-Charleroi, 6000, Charleroi, Belgium. mmanto@ulb.ac.be.
Nicolas DupreDepartment of Medicine, Faculty of Medicine, Université Laval & Neuroscience Axis, CHU de Québec-Université Laval, Quebec City, QC, Canada.
Marios HadjivassiliouAcademic Department of Neurosciences, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.
Elan D LouisDepartment of Neurology and Neurotherapeutics, University of Texas Southwestern, Dallas, TX, USA.
Hiroshi MitomaDepartment of Medical Education, Tokyo Medical University, Tokyo, Japan.
Marco MolinariIRCCS Fondazione S. Lucia, Rome, Italy.
Aasef G ShaikhDepartment of Neurology, Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland VA Medical Center, Cleveland, OH, USA.
Bing-Wen SoongTaipei Neuroscience Institute, Taipei Medical University, Taipei, Taiwan.
Michael StruppDepartment of Neurology, Ludwig Maximilians University, Munich, Germany.
Frank Van OverwalleBrain, Body and Cognition Lab, Faculty of Psychology, Vrije Universiteit Brussel, Brussels, Belgium.
Jeremy D SchmahmannAtaxia Center, Cognitive Behavioral Neurology Unit, Laboratory for Neuroanatomy and Cerebellar Neurobiology, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Case Western Reserve University · USFondazione Santa Lucia · ITGrand Charleroi Hospital · BEHarvard University · USLudwig-Maximilians-Universität München · DESheffield Teaching Hospitals NHS Foundation Trust · GBTaipei Medical University · TWThe University of Texas Southwestern Medical Center · USTokyo Medical University · JPUniversité Laval · CAVrije Universiteit Brussel · BE

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

The current worldwide severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic that causes coronavirus disease 2019 (COVID-19) has brought some medical systems to the brink of collapse. This crisis is also negatively impacting the care of patients with non-COVID-19 conditions, including those with cerebellar ataxia (CA). Older patients with CA and those with immune-mediated ataxias on immunosuppressive medication are potentially at high risk of developing serious complications of the infection, although it is also possible that immunosuppressive agents may provide a defense against cytokine storm. This has implications for even greater attention to preventing contracting the disease through physical distancing and/or isolation. The CA patient population is also at higher risk because of the neurological complexities of their underlying disorder and the comorbid medical illnesses that often accompany the genetic ataxias. As the disruption of social patterns and healthcare delivery in response to the crisis continues, interruption of rehabilitation, speech and language therapy, and face-to-face consultations threatens to have a negative impact on the course and well-being of CA patients. Mental and physical health is also potentially at greater risk because the prevailing uncertainty and anxiety may be superimposed upon cerebellum-specific neuropsychological challenges. We identify and review some of the short- and long-term consequences of this global pandemic for the community of ataxia patients and their families and for the clinical and academic neurologists/ataxiologists caring for these patients. This includes the recognition that telemedicine has emerged as a principle means of caregiver-patient contact and that neurological manifestations of COVID-19 including those specific to cerebellar neurobiology are increasingly recognized and will require close surveillance and monitoring. This COVID-19 Cerebellum Task Force consensus provides some guidance on how we may approach this uncertain time and consider preparing for the new realities we face in CA patient care once this acute crisis has passed.

Indexed as

Cerebellar AtaxiaCoronavirus InfectionsPandemicsPneumonia, ViralBetacoronavirusComorbidityCOVID-19HumansRisk FactorsSARS-CoV-2Cerebellar ataxiaCerebellumCOVID-19SARS-CoV-2

Identifiers

PMID32405955
PMCPMC7220536
OpenAlexW3025702307

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.